![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PJA1 |
Gene summary for PJA1 |
![]() |
Gene information | Species | Human | Gene symbol | PJA1 | Gene ID | 64219 |
Gene name | praja ring finger ubiquitin ligase 1 | |
Gene Alias | PRAJA1 | |
Cytomap | Xq13.1 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | Q8NG27 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
64219 | PJA1 | LZE4T | Human | Esophagus | ESCC | 5.26e-03 | 1.12e-01 | 0.0811 |
64219 | PJA1 | LZE7T | Human | Esophagus | ESCC | 2.33e-08 | 2.96e-01 | 0.0667 |
64219 | PJA1 | LZE8T | Human | Esophagus | ESCC | 3.14e-03 | 2.05e-01 | 0.067 |
64219 | PJA1 | LZE20T | Human | Esophagus | ESCC | 7.77e-10 | 2.21e-01 | 0.0662 |
64219 | PJA1 | LZE24T | Human | Esophagus | ESCC | 3.07e-15 | 5.06e-01 | 0.0596 |
64219 | PJA1 | LZE21T | Human | Esophagus | ESCC | 2.24e-03 | 1.83e-01 | 0.0655 |
64219 | PJA1 | P1T-E | Human | Esophagus | ESCC | 9.40e-05 | 2.07e-01 | 0.0875 |
64219 | PJA1 | P2T-E | Human | Esophagus | ESCC | 4.37e-20 | 4.63e-01 | 0.1177 |
64219 | PJA1 | P4T-E | Human | Esophagus | ESCC | 1.71e-16 | 3.50e-01 | 0.1323 |
64219 | PJA1 | P5T-E | Human | Esophagus | ESCC | 5.96e-09 | 9.14e-02 | 0.1327 |
64219 | PJA1 | P8T-E | Human | Esophagus | ESCC | 1.12e-28 | 6.09e-01 | 0.0889 |
64219 | PJA1 | P9T-E | Human | Esophagus | ESCC | 1.02e-10 | 2.07e-01 | 0.1131 |
64219 | PJA1 | P10T-E | Human | Esophagus | ESCC | 4.03e-17 | 3.78e-01 | 0.116 |
64219 | PJA1 | P11T-E | Human | Esophagus | ESCC | 6.87e-14 | 5.25e-01 | 0.1426 |
64219 | PJA1 | P12T-E | Human | Esophagus | ESCC | 6.26e-49 | 1.07e+00 | 0.1122 |
64219 | PJA1 | P15T-E | Human | Esophagus | ESCC | 1.75e-25 | 4.05e-01 | 0.1149 |
64219 | PJA1 | P16T-E | Human | Esophagus | ESCC | 1.51e-30 | 6.13e-01 | 0.1153 |
64219 | PJA1 | P17T-E | Human | Esophagus | ESCC | 1.49e-08 | 3.58e-01 | 0.1278 |
64219 | PJA1 | P19T-E | Human | Esophagus | ESCC | 1.15e-03 | 3.92e-01 | 0.1662 |
64219 | PJA1 | P20T-E | Human | Esophagus | ESCC | 7.16e-17 | 2.31e-01 | 0.1124 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PJA1 | SNV | Missense_Mutation | c.1889N>A | p.Gly630Asp | p.G630D | Q8NG27 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-UF-A71D-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PJA1 | SNV | Missense_Mutation | rs180767696 | c.1190N>T | p.Pro397Leu | p.P397L | Q8NG27 | protein_coding | deleterious(0.04) | benign(0.001) | TCGA-KK-A59V-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Unknown | Unknown | SD |
PJA1 | SNV | Missense_Mutation | c.1698N>A | p.Asn566Lys | p.N566K | Q8NG27 | protein_coding | deleterious(0.01) | probably_damaging(0.979) | TCGA-BR-4368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
PJA1 | SNV | Missense_Mutation | rs760451597 | c.122G>A | p.Arg41Gln | p.R41Q | Q8NG27 | protein_coding | tolerated(1) | benign(0) | TCGA-CD-A48A-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | capecitabine | CR |
PJA1 | SNV | Missense_Mutation | c.847A>G | p.Met283Val | p.M283V | Q8NG27 | protein_coding | tolerated(1) | benign(0) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
PJA1 | SNV | Missense_Mutation | c.1174N>G | p.Ser392Gly | p.S392G | Q8NG27 | protein_coding | deleterious(0) | benign(0.027) | TCGA-D7-A4Z0-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracilum | SD | |
PJA1 | SNV | Missense_Mutation | c.347N>T | p.Gly116Val | p.G116V | Q8NG27 | protein_coding | tolerated(0.72) | probably_damaging(0.998) | TCGA-HJ-7597-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | CR | |
PJA1 | SNV | Missense_Mutation | rs147196192 | c.149C>T | p.Thr50Met | p.T50M | Q8NG27 | protein_coding | tolerated(0.09) | probably_damaging(0.994) | TCGA-VQ-A91D-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |